Silence Therapeutics Plc (SLNCF)

2.600 +0.60 (+30.00%) USD  |  OTCM  |  Apr 10, 16:00
More

Silence Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Adaptimmune Therapeutics Plc Upgrade
Biodexa Pharmaceuticals Plc Upgrade
Oxford Biomedica Plc Upgrade
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade